| Firm | Analyst | Phone | | Brean Murray, Carret & Co. | Jonathon Aschoff | 212-702-6652 | | Citigroup Global Markets, Inc. | Lucy Lu | 212-816-1441 | | Collins Stewart, LLC | Salveen Kochnover | 212-389-8052 | | Cowen & Co. LLC | Eric Schmidt | 646-562-1345 | | Deutsche Bank Securities, Inc. | David M. Steinberg | 415-617-3296 | | Jefferies & Company, Inc. | Eun Yang | 212-284-2264 | | Leerink Swann, LLC | Joe Schwartz | 617-918-457 | | Morgan Stanley | Marshall Urist | 212-761-8055 | | Oppenheimer & Co. | John Newman | 212-667-7325 | | Pacific Growth Equities | Kim Lee | 415-274-6842 | | Piper Jaffray & Co. | Thomas Wei | 212-284-9305 | | Roth Capital Partners, LLC | Scott Henry | 949-720-7123 | | Stanford Group Company | Biren Amin | 561-544-8321 | | Thomas Weisel Partners Group Inc. | Aaron Mishel | 415-364-2695 |
|
 |
| Auxilium Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Auxilium Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Auxilium Pharmaceuticals, Inc. or its management. Auxilium Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. |
|
